Over the past few years there have been substantial advances in our knowledge of
premalignant lesions of the pancreas. Given the dismal prognosis of untreated pancreatic …

Pancreatic cancer (PC) is the most common type of malignancy of the pancreas. Majority of
PCs are ductal adenocarcinomas and variants. PC is the 4th leading cause of cancer death …

Aims Current guidelines for pathology reporting on pancreatic cancer differ in certain
aspects, resulting in divergent reporting practices and a lack of comparability of data. Here …

Introduction Pancreatic ductal adenocarcinoma (PDAC) is a major public health issue with
an incidence/mortality ratio reaching 98%. Only 15–20% of patients with PDAC can undergo …

BACKGROUND Identifying high‐grade features in patients with pancreatic mucinous
neoplasms (MNs) is important for patient management. The reproducibility of MN cytology …

Background Intraductal papillary mucinous neoplasms (IPMNs) are the precursor lesions of
pancreatic cancers, requiring active surgical intervention during cancer development …

Background: Pancreatic tumors have a large diversity, with an increasing incidence and
mortality. Although the diagnosis methods have improved in recent years, establishing a …

Context.—The pancreas gives rise to an array of distinct neoplasms that can be solid, cystic,
or intraductal and can recapitulate the various lines of differentiation present in the normal …

This issue of Surgical Pathology Clinics, edited by Drs. Laura Wood and Lodewijk Brosens,
will cover the current research and concepts on Pancreatic Pathology. Topics discussed will …

There is great interest in an ability to categorize pancreatic cancer, and understand and
classify the significant heterogeneity that exists in this disease. Such classifications based …